Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders ; volume:6 ; number:1 ; day:27 ; month:12 ; year:2018 ; pages:1-10 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (27.12.2018), 1-10, 12.2018
- Urheber
-
Boilève, A.
Carlo, M. I.
Barthélémy, P.
Oudard, S.
Borchiellini, D.
Voss, M. H.
George, S.
Chevreau, C.
Landman-Parker, J.
Tabone, M-D
Chism, D. D.
Amin, A.
Bilen, M. A.
Bosse, D.
Coulomb-L’hermine, A.
Su, Xiaoping
Choueiri, T. K.
Tannir, Nizar M.
Malouf, Gabriel G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-018-0482-z
- URN
-
urn:nbn:de:101:1-2019021416254024186685
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boilève, A.
- Carlo, M. I.
- Barthélémy, P.
- Oudard, S.
- Borchiellini, D.
- Voss, M. H.
- George, S.
- Chevreau, C.
- Landman-Parker, J.
- Tabone, M-D
- Chism, D. D.
- Amin, A.
- Bilen, M. A.
- Bosse, D.
- Coulomb-L’hermine, A.
- Su, Xiaoping
- Choueiri, T. K.
- Tannir, Nizar M.
- Malouf, Gabriel G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Xp11.2 translocation renal cell carcinomas in young adults
Polygenic risk scores for autoimmune related diseases are significantly different in cancer exceptional responders
Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance
Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors
Identification of responders to immune checkpoint therapy : which biomarkers have the highest value?
Exceptional dynamics at exceptional points
Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
Translocation
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
Xp11.2 translocation renal cell carcinomas in young adults
Polygenic risk scores for autoimmune related diseases are significantly different in cancer exceptional responders
Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance
Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors
Identification of responders to immune checkpoint therapy : which biomarkers have the highest value?
Exceptional dynamics at exceptional points
Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
Translocation
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
Xp11.2 translocation renal cell carcinomas in young adults
Polygenic risk scores for autoimmune related diseases are significantly different in cancer exceptional responders
Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance
Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors
Identification of responders to immune checkpoint therapy : which biomarkers have the highest value?
Exceptional dynamics at exceptional points
Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
Translocation